Posttransplantation course after allogeneic stem cell transplantation in a patient with advanced mycosis fungoides—Balancing relapse and rejection

Posttransplantation course after allogeneic stem cell transplantation in a patient with advanced mycosis fungoides—Balancing relapse and rejection

Abstract Treatment of advanced cutaneous T‐cell lymphoma (CTCL) can be challenging. To date, the only potentially curative treatment option for advanced CTCL is allogeneic hematopoietic stem cell transplantation. We report on a patient with mycosis fungoides who received allogeneic hematopoietic ste...

Full description

Saved in:

Bibliographic Details
Main Authors:	Inga Hansen‐Abeck, Chiara L. Blomen, Finn Abeck, Leopold Torster, Stefan W. Schneider, Nina Booken
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	JEADV Clinical Practice
Subjects:	allogeneic stem cell transplantation cutaneous T‐cell lymphoma graft‐versus‐host disease mycosis fungoides
Online Access:	https://doi.org/10.1002/jvc2.514
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Application of immunohistochemical markers in mycosis fungoides
by: SHAO Kaixin, et al.
Published: (2025-01-01)

Kasr-Al-Ainy cutaneous lymphoma unit protocol for management of mycosis fungoides
by: Randa Youssef, et al.
Published: (2024-01-01)

Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients
by: Hongbin Song, et al.
Published: (2024-12-01)

Dermoscopy in the diagnosis of mycosis fungoides
by: Olga G. Artamonova, et al.
Published: (2024-11-01)

Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
by: Francine Foss, et al.
Published: (2025-12-01)

A Case Series of Diagnostic Challenges in Mycosis Fungoides in Resource-poor Settings: Blood Film Examination – A Useful Tool
by: Erere Otrofanowei, et al.
Published: (2024-12-01)

Predicting Prognosis of Early-Stage Mycosis Fungoides with Utilization of Machine Learning
by: Banu İsmail Mendi, et al.
Published: (2024-10-01)

Hypopigmented mycosis fungoides: an important differential diagnosis of hypochromias in childhood
by: Maria Fernanda de Almeida Cavalcante Aranha, et al.
Published: (2025-01-01)

Folliculotropic mycosis fungoides of the face successfully treated combining CO2 laser and conventional photodynamic therapy (c-PDT)
by: Biagio Scotti, et al.
Published: (2024-12-01)

MYCOSIS FUNGOIDES PROGRESSING TO PERIPHERAL T-CELL LYMPHOMA AND THE POTENTIAL ROLE OF ROMIDEPSIN THERAPY
by: Bengisu Ece Duman, et al.
Published: (2024-12-01)

The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue
by: Angelica Johansson, et al.
Published: (2025-01-01)

Dermoscopy of Early-Stage Mycosis Fungoides: Comparative Study with Inflammatory Dermatoses
by: Amel Chabbouh, et al.
Published: (2025-01-01)

Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians
by: Larisa Geskin, et al.
Published: (2024-11-01)

The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression
by: Yige Zhao, et al.
Published: (2025-02-01)

GATA3 as a Prognostic Marker in Early‐Stage Classical Mycosis Fungoides: Association With Disease Progression and Survival Outcomes
by: Pengfei Wen, et al.
Published: (2025-09-01)

A retrospective study of prognostic factors and treatment outcome in advanced-stage Mycosis Fungoides and Sezary Syndrome
by: Zhuo-fan Xu, et al.
Published: (2024-12-01)

Keratoderma-Like T-Cell Dyscrasia: A Case Report
by: Asem Shadid, et al.
Published: (2024-10-01)

Mikozis fungoides tedavisinde dbUVB ve PUVA: Retrospektif değerlendirme
by: Gülbahar Ürün Unal, et al.
Published: (2015-09-01)

Case report: Canadian consensus on chlormethine gel use in mycosis fungoides-CTCL: literature review and real-world experience
by: Ivan V. Litvinov, et al.
Published: (2024-12-01)

Helikobakter pilori enfeksiyonu Mikozis fungoides için risk faktörü müdür?
by: Hanife Merve Akça, et al.
Published: (2013-01-01)

DEPTOR levels in patients with mycosis fungoides
by: Aslı Aksu Çerman, et al.
Published: (2024-11-01)

The notch sign as a clue for the diagnosis of early cutaneous T-cell lymphoma
by: Evelyne Harkemanne, MD, PhD, et al.
Published: (2025-02-01)

Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
by: Lina U. Ivert, et al.
Published: (2024-12-01)

Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
by: Lina U. Ivert, et al.
Published: (2024-08-01)

Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
by: Jongbok Lee, et al.
Published: (2025-01-01)

Syringotropic Lichen Planus: An Unusual Presentation of a Common Dermatosis – A Report of 2 Cases
by: Fatemeh Mohaghegh, et al.
Published: (2024-10-01)

Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions
by: Muhammad Azhar Ud Din, et al.
Published: (2025-01-01)

THE TREATMENT OF ADVANCED-STAGE MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A HEMATOLOGIST'S POINT OF VIEW.
by: Antonio Giordano, et al.
Published: (2022-02-01)

Four cases of renal injury associated with allogeneic haematopoietic stem cell transplantation and literature review
by: Dong Ze-xuan, et al.
Published: (2025-01-01)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-08-01)

CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Luca Castagna, et al.
Published: (2015-02-01)

Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients
by: Gianmarco Bagnato, et al.
Published: (2024-01-01)

Implementing a standardized workflow for early detection of steroid-induced hyperglycemia in allogeneic stem cell transplant recipients: A quality improvement project
by: Jordan Leal, et al.
Published: (2024-12-01)

Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study)
by: Annemarie Glöckner, et al.
Published: (2025-01-01)

Candidiasis Opportunistic Mycosis within Nigeria: A Review
by: Sule, H.,, et al.
Published: (2019-06-01)

Ocular graft host disease after allogeneic stem cell transplant: unique risk factors and outcomes
by: Maaly A.M Abdel Fattah, et al.
Published: (2024-04-01)

Clonal GZMK+CD8+ T cells are identified as a hallmark of the pathogenesis of cGVHD-induced bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantationResearch in context
by: Yang Gao, et al.
Published: (2025-02-01)

The influence of immune checkpoint blockade on the outcomes of allogeneic hematopoietic stem cell transplantation
by: Yalei Hu, et al.
Published: (2024-11-01)

Targeting the chemokines in acute graft-versus-host disease
by: Ziwei Xu, et al.
Published: (2025-01-01)

Cutaneous manifestations associated with unknown HIV infection: a case report
by: Paolo Iacovelli, et al.
Published: (2025-01-01)